Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
PHARMARON Surges 8%+ at Midday as Nomura Raises TP
Recommend 2 Positive 3 Negative 2 |
||||
|
||||
|
PHARMARON (03759.HK) opened 2.87% higher today and once peaked at HKD20.64. It ended the midday at HKD20.44, up 8.61%, with a trading volume of 9.5382 million shares, involving HKD190 million. Nomura's report said PHARMARON's 4Q25 results met expectations, with revenue and earnings growing by 16% and 41% YoY, respectively. During the earnings call, PHARMARON's management projected that revenue in 2026 will grow by 12-18% YoY, which aligned with market expectations at the midpoint but exceeded Nomura's previous estimates. This growth guidance has factored in exchange rate effects; Otherwise, actual growth would be 3 ppts higher. Nomura has kept a Buy rating on PHARMARON and increased its target price from HKD26.63 to HKD27.33. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
